GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Europharma Co Ltd (ROCO:4120) » Definitions » Gross-Profit-to-Asset %

Orient Europharma Co (ROCO:4120) Gross-Profit-to-Asset % : 19.05% (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Orient Europharma Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Orient Europharma Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was NT$2,228 Mil. Orient Europharma Co's average Total Assets over the quarter that ended in Mar. 2025 was NT$11,696 Mil. Therefore, Orient Europharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 19.05%.


Orient Europharma Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Orient Europharma Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Europharma Co Gross-Profit-to-Asset % Chart

Orient Europharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.21 24.49 20.49 20.22 18.46

Orient Europharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.43 18.07 15.67 17.48 19.05

Competitive Comparison of Orient Europharma Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Orient Europharma Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orient Europharma Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orient Europharma Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Orient Europharma Co's Gross-Profit-to-Asset % falls into.


;
;

Orient Europharma Co Gross-Profit-to-Asset % Calculation

Orient Europharma Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=2066.17/( (10811.794+11570.285)/ 2 )
=2066.17/11191.0395
=18.46 %

Orient Europharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=2228.392/( (11570.285+11822.018)/ 2 )
=2228.392/11696.1515
=19.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Orient Europharma Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Orient Europharma Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orient Europharma Co Business Description

Traded in Other Exchanges
N/A
Address
13th Floor, No. 128, Chengde Rd., Section 6, Beitou Distrit, Taipei, TWN, 112052
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.

Orient Europharma Co Headlines

No Headlines